Another inflammatory gene signature, mainly involving IRF7/9 and STAT5B, which are associated with chemoresistance in refractory ETP-ALL (Jason et al., 2024-11), was also significantly relevant to CNL-5 risk scores (Supplementary Figure 8). This evidence concerns the gene STAT5B and acute lymphoblastic leukemia.